Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells

World Journal of Gastroenterology

Volumn 12, Issue 33, 2006, Pages 5331-5335

  Yang, Wen Yu ^a   Huang, Zong Hai ^a   Lin, Li Jun ^a   Li, Zhou ^a   Yu, Jing Long ^a   Song, Hui Juan ^a   Qian, Yong ^b   Che, Xiao Yan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Double suicide gene system; Human umbilical vein endothelial cells; Targeted killing

Indexed keywords

ADENOVIRUS VECTOR; FLUCYTOSINE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; PRODRUG; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL GROWTH; CELL KILLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; DRUG TARGETING; ENDOTHELIUM CELL; GENE CONSTRUCT; GENETIC REGULATION; GENETIC TRANSFECTION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; INFECTION RATE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; SUICIDE GENE; UMBILICAL VEIN; VIRUS RECOMBINANT;

EID: 33749372197     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i33.5331     Document Type: Article

References (30)

1. Zeng M, Smith SK, Siegel F, Shi Z, Van Kampen KR, Elmets CA, Tang DC. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques 2001; 31: 260-262
2. He Y, Zhou J, Wu JS, Dou KF. Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line. World J Gastroenterol 2000; 6: 747-749
3. Fan YF, Huang ZH. Progress in the studies of gene therapy for colorectal cancer. Shijie Huaren Xiaohua Zazhi 2001; 9: 427-430
4. Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res 2003; 63: 7400-7409
5. Mentlein R, Held-Feindt J. Angiogenesis factors in gliomas: a new key to tumour therapy? Naturwissenschaften 2003; 90: 385-394
6. Li Y, Jin Y, Chen H, Jie G, Tobelem G, Caen JP, Han ZC. Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4. Cancer Biother Radiopharm 2003; 18: 829-840
7. Lamszus K, Kunkel P, Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003; 88: 169-177
8. Yang SH, Lin JK, Chen WS, Chiu JH. Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J Surg Res 2003; 113: 133-138
9. Longo R, Sarmiento R, Fanelli M, Capaccetti B, Gattuso D, Gasparini G. Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis 2002; 5: 237-256
10. Jiao LR, Havlik R, Nicholls J, Jensen SL, Habib NA. Suicide gene therapy in liver tumors. Methods Mol Med 2004; 90: 433-450
11. Miyagi T, Koshida K, Hori O, Konaka H, Katoh K Kitagawa Y, Mizokami A, Egawa M, Ogawa S, Hamada H, Namiki M. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. J Gene Med 2003; 5: 30-37
12. Brown NL, Lemoine NR. Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine. Methods Mol Med 2004; 90: 451-457
13. Porosnicu M, Mian A, Barber GN. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Cancer Res 2003; 63: 8366-8376
14. Pogulski KR, Kim JH, Kim SH, Freytag SO. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 1997; 8: 73-85
15. Jiang YR, Ma DX, Chen XL, Liu CS. Killing effect of double suicide genes mediated by lentivirus on lymphoma cells. Ai Zheng 2003; 22: 916-921
16. Li XJ, Wang KM, Xu Y, Wang ZH, Xia AD, Chen SS, Qian GX. Ionizing radiation-regulated killing of human hepatoma cells by liposome-mediated CDglyTK gene delivery. Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 2003; 35: 64-70
17. Corban-Wilhelm H, Becker G, Bauder-Wust U, Greulich D, Debus J. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity. Clin Exp Med 2003; 3: 150-156
18. Hoganson DK, Batra RK, Olsen JC, Boucher RC. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res 1996; 56: 1315-1323
19. Kenneth RR, Jae HK, Sang HK, Svend OF. Glioma cells transduced with an Escherichia coli CD/HSV-1TK fushion gene exhibit enhanced metabolic suicide and radiosensitivity. Human Gene Therapy 1997; 8: 73-85
20. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995; 55: 4808-4812
21. Ear T, Giguere P, Fleury A, Stankova J, Payet MD, Dupuis G. High efficiency transient transfection of genes in human umbilical vein endothelial cells by electroporation. J Immunol Methods 2001; 257: 41-49
22. Patterson C, Perrella MA, Hsieh CM, Yoshizumi M, Lee ME, Haber E. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem 1995; 270: 23111-23118
23. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6
24. Jakobisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett 2003; 90: 103-122
25. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998
26. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DS, Folkman J. Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 1981; 78: 1176-1180
27. Gee MS, Koch CJ, Evans SM, Jenkins WT, Pletcher CH Jr, Moore JS, Koblish HK, Lee J, Lord EM, Trinchieri G, Lee WM. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12. Cancer Res 1999; 59: 4882-4889
28. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
29. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997; 272: 23659-23667
30. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71